Nasrin Sarafan‐Vasseur

Author

Inserm ORCID

Also Known As

N. Sarafan-Vasseur, N. Sarafan-vasseur, Nasrin Sarafan-Vasseur, Nasrin Sarafan‐Vasseur, Sarafan-Vasseur, Nasrin

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Inserm Université de Rouen Normandie Normandie Université Centre Henri Becquerel Centre Virchow-Villermé

About

Nasrin Sarafan‐Vasseur is an author at Inserm specializing in medicine, pathology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	575
2	Engineering	4	4	173
3	Health Sciences	1	1	81
4	Biostatistics	1	1	31
5	Cell Biology	1	1	32

Nasrin Sarafan‐Vasseur

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study) Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui, Clinical Cancer Research	2017	243
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours David Sefrioui, France Blanchard, Emmanuel Touré, British Journal of Cancer	2017	116
Kinetics, prognostic and predictive values of <i>ESR1</i> circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor Florian Clatot, Anne Perdrix, Laetitia Augusto, Oncotarget	2016	95
Gradual reduction of BUBR1 protein levels results in premature sister-chromatid separation then in aneuploidy Élodie Bohers, Nasrin Sarafan‐Vasseur, Aurélie Drouet, Human Genetics ChromatinGenome InstabilityCell DivisionCytogeneticsGenetic Disorder	2008	94
Short report: Monitoring <scp><i>ESR</i></scp><i>1</i> mutations by circulating tumor <scp>DNA</scp> in aromatase inhibitor resistant metastatic breast cancer David Sefrioui, Anne Perdrix, Nasrin Sarafan‐Vasseur, International Journal of Cancer Breast OncologyEngineeringClear Esr1 MutationPathologyEsr1 Mutations	2015	82
Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma Vincent Camus, Nasrin Sarafan‐Vasseur, Élodie Bohers, Leukemia & lymphoma/Leukemia and lymphoma ImmunologyDna AnalysisPathologyTumor BiologyFree Dna	2016	81
Overexpression of B-type cyclins alters chromosomal segregation Nasrin Sarafan‐Vasseur, Aude Lamy, Jeannette Bourguignon, Oncogene ChromatinCytogeneticsGeneticsMolecular BiologyChromosome Biology	2002	76
Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer David Sefrioui, Nasrin Sarafan‐Vasseur, Ludivine Beaussire, Digestive and Liver Disease EngineeringNucleic Acid BiomarkersCancer DetectionMedicineChip-based Digital-pcr Platform	2015	68
The Rapp–Hodgkin syndrome results from mutations of the TP63 gene Gaëlle Bougeard, S. Hadj‐Rabia, Laurence Faivre, European Journal of Human Genetics Rapp–hodgkin Syndrome ResultsGenetic DisorderImmunodeficienciesPathogenesisImmunology	2003	65
Contribution of theBOP1 gene, located on 8q24, to colorectal tumorigenesis Audrey Killian, Nasrin Sarafan‐Vasseur, Richard Sesboüé, Genes Chromosomes and Cancer	2006	59

Page 1